Novo CEO pressed by Senate to chop costs of being overweight, diabetes prescription drugs CEO Lars Fruergaard Jørgensen advised lawmakers the corporation would contemplate new talks with insurers in regards to the list price ranges of Wegovy and copyright if they pledge to maintain the medicines on their own formularies. https://knoxqsstv.bluxeblog.com/62749047/the-smart-trick-of-healthcare-news-that-nobody-is-discussing